Published in Blood on January 27, 2005
The transcriptome of the salivary glands of the female western black-legged tick Ixodes pacificus (Acari: Ixodidae). Insect Biochem Mol Biol (2005) 1.39
Tissue factor pathway inhibitor: structure-function. Front Biosci (Landmark Ed) (2012) 1.28
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. J Thromb Haemost (2008) 1.02
Alternatively spliced isoforms of tissue factor pathway inhibitor. Thromb Res (2010) 0.98
Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ. J Thromb Haemost (2013) 0.90
Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions. Anal Biochem (2010) 0.83
Investigation of a potential scintigraphic tracer for imaging apoptosis: radioiodinated annexin V-Kunitz protease inhibitor fusion protein. J Biomed Biotechnol (2011) 0.77
Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor. J Thromb Haemost (2013) 0.77
Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft. PLoS One (2015) 0.75
Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem (1989) 29.15
Annexins: from structure to function. Physiol Rev (2002) 6.78
A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 6.12
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood (1997) 4.01
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
A cell-based model of hemostasis. Thromb Haemost (2001) 2.99
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials (2004) 2.80
Properties of the factor Xa binding site on human platelets. J Biol Chem (1978) 2.59
Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol (2002) 2.53
Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res (2002) 2.21
Blood clotting in minimally altered whole blood. Blood (1996) 2.10
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest (1993) 2.00
Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest (2004) 1.74
Lipid-protein interactions in blood coagulation. Biochim Biophys Acta (1998) 1.62
Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res (1997) 1.61
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood (2004) 1.57
Unraveling the mysteries of phospholipid scrambling. Thromb Haemost (2001) 1.57
Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood (2000) 1.47
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood (1996) 1.39
Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem (1985) 1.33
Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation (2003) 1.32
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem (1993) 1.23
Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology (N Y) (1994) 1.22
Human placental anticoagulant protein: isolation and characterization. Biochemistry (1987) 1.18
The complexity of the phospholipid binding protein Annexin V. Thromb Haemost (1995) 1.17
Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. J Biol Chem (1990) 1.14
Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest (1993) 1.07
Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis (1995) 1.06
Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost (2004) 1.05
Factor VIIa-tissue factor: functional importance of protein-membrane interactions. Thromb Haemost (1997) 1.04
Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem (1996) 1.03
Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thromb Haemost (2001) 0.98
Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb Haemost (1994) 0.97
Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost (1995) 0.96
Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa. Biochemistry (1990) 0.95
Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res (1994) 0.95
Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis. Cancer Biother Radiopharm (2003) 0.94
Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2000) 0.92
Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Biochemistry (1994) 0.91
Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation (1995) 0.91
Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res (2003) 0.90
In-vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res (1991) 0.89
Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition. Thromb Res (1991) 0.89
Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells. Thromb Haemost (1992) 0.89
Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex. J Biol Chem (1995) 0.89
Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation (1997) 0.87
Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties. Thromb Haemost (1995) 0.87
Titration of activated bovine Factor X. J Biol Chem (1973) 0.86
Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation (1997) 0.85
Apoptosis as a determinant of atherothrombosis. Thromb Haemost (2001) 0.85
Inhibition of prothrombinase complex by plasma proteinase inhibitors. Biochemistry (1984) 0.84
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood (2002) 0.84
Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus (2003) 0.84
Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor. Biochem J (1997) 0.82
Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex. Thromb Res (2000) 0.81
Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors. J Reconstr Microsurg (1995) 0.79
Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost (1996) 0.79
The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost (1993) 0.78
Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo. Blood (2000) 0.77
Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity. Blood Coagul Fibrinolysis (2003) 0.77
Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo. Thromb Haemost (1995) 0.76
Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI. Ann Med (2000) 0.76
Light-mediated activation reveals a key role for Rac in collective guidance of cell movement in vivo. Nat Cell Biol (2010) 2.45
Effect of thimerosal on the neurodevelopment of premature rats. World J Pediatr (2013) 2.04
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol (2003) 1.83
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol (2004) 1.62
Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev (2009) 1.52
Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev (2013) 1.50
NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. J Biol Chem (2005) 1.47
Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol (2008) 1.44
A contractile actomyosin network linked to adherens junctions by Canoe/afadin helps drive convergent extension. Mol Biol Cell (2011) 1.22
The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo. Blood (2003) 1.21
Spatiotemporal control of small GTPases with light using the LOV domain. Methods Enzymol (2011) 1.18
Heparin cofactor II inhibits arterial thrombosis after endothelial injury. J Clin Invest (2002) 1.18
Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II. J Biol Chem (2001) 1.17
Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II. Blood (2011) 1.12
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice. Blood (2004) 1.10
Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J Biol Chem (2012) 1.08
Comparison of dry eye and corneal sensitivity between small incision lenticule extraction and femtosecond LASIK for myopia. PLoS One (2013) 1.06
EEG-fMRI study on the interictal and ictal generalized spike-wave discharges in patients with childhood absence epilepsy. Epilepsy Res (2009) 1.05
miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect (2013) 1.04
Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors. Mol Cell Biochem (2011) 1.03
Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II). PLoS One (2011) 1.02
Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev (2014) 1.01
TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway. J Immunol (2012) 1.00
Perifosine sensitizes UVB-induced apoptosis in skin cells: new implication of skin cancer prevention? Cell Signal (2012) 0.99
A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice. Mol Ther (2009) 0.97
Postherpetic neuralgia in herpes zoster. JAMA (2009) 0.96
MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines. J Cell Biochem (2015) 0.96
Acupuncture for Bell's palsy. Cochrane Database Syst Rev (2010) 0.95
Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells. PLoS One (2011) 0.95
Ultra-violet B (UVB)-induced skin cell death occurs through a cyclophilin D intrinsic signaling pathway. Biochem Biophys Res Commun (2012) 0.94
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost (2011) 0.93
Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury. Blood (2008) 0.93
[Detection of cell apoptosis in the pathological tissues of patients with SARS and its significance]. Di Yi Jun Yi Da Xue Xue Bao (2003) 0.93
Gene expression signatures in tree shrew sclera in response to three myopiagenic conditions. Invest Ophthalmol Vis Sci (2013) 0.93
Malignant glomus tumour of the lung. Pathology (2010) 0.92
micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. J Neurosci (2010) 0.92
Pseudotumor cerebri syndrome and giant arachnoid granulation: treatment with venous sinus stenting. J Vasc Interv Radiol (2010) 0.92
[Application of hydrogen proton magnetic resonance spectrum in hypoxic-ischemic encephalopathy in full-term neonates]. Zhonghua Er Ke Za Zhi (2008) 0.91
BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol (2011) 0.91
Growth and fabrication of InAs/GaSb type II superlattice mid-wavelength infrared photodetectors. Nanoscale Res Lett (2011) 0.91
Border cell migration: a model system for live imaging and genetic analysis of collective cell movement. Methods Mol Biol (2011) 0.90
Variations on the SnCl4 and CF3CO2Ag-promoted glycosidation of sugar acetates: a direct, versatile and apparently simple method with either alpha or beta stereocontrol. Carbohydr Res (2009) 0.90
[Urinary S100B protein and lactate/creatinine ratio measurements: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy]. Zhonghua Er Ke Za Zhi (2005) 0.90
Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest (2009) 0.89
Public knowledge of stroke in Chinese urban residents: a community questionnaire study. Neurol Res (2011) 0.89
Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood (2008) 0.89
Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC. J Control Release (2008) 0.89
Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infect Dis (2013) 0.88
[Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]. Di Yi Jun Yi Da Xue Xue Bao (2003) 0.87
The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption. Bone (2012) 0.87
P-type 3C-SiC nanowires and their optical and electrical transport properties. Chem Commun (Camb) (2011) 0.86
Aberrant functional connectivity of resting state networks in transient ischemic attack. PLoS One (2013) 0.86
Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens. Neuropsychopharmacology (2007) 0.86
Proteolytic activation transforms heparin cofactor II into a host defense molecule. J Immunol (2013) 0.85
LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China. Brain Res (2009) 0.85
Traditional Chinese medicine for epilepsy. Cochrane Database Syst Rev (2009) 0.85
Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice. Blood (2007) 0.85
Pro-photoreceptor activity of chick neurogenin1. Invest Ophthalmol Vis Sci (2009) 0.85
DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival. Mol Cancer (2013) 0.85
Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev (2010) 0.85
Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells. Cancer Lett (2011) 0.85
Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces. Nanotechnology (2014) 0.84
Sanchi for acute ischaemic stroke. Cochrane Database Syst Rev (2008) 0.84
Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev (2010) 0.84
Arctigenin alleviates ER stress via activating AMPK. Acta Pharmacol Sin (2012) 0.84
Degradation of glyphosate in soil photocatalyzed by Fe3O4/SiO2/TiO2 under solar light. Int J Environ Res Public Health (2011) 0.84
Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res (2014) 0.83
Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells. Cancer Sci (2012) 0.83
Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions. Anal Biochem (2010) 0.83
Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. Blood (2005) 0.83
Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients. Genet Test Mol Biomarkers (2014) 0.83
Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev (2011) 0.83
Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients. Acta Radiol (2011) 0.83
Optical quality and intraocular scattering after femtosecond laser small incision lenticule extraction. J Refract Surg (2014) 0.82
Nuclear and cytoplasmic genome components of Solanum tuberosum + S. chacoense somatic hybrids and three SSR alleles related to bacterial wilt resistance. Theor Appl Genet (2013) 0.82
Inexact rough-interval two-stage stochastic programming for conjunctive water allocation problems. J Environ Manage (2009) 0.82
Meiotic behavior of pollen mother cells in relation to ploidy level of somatic hybrids between Solanum tuberosum and S. chacoense. Plant Cell Rep (2010) 0.82
Steroidal saponins with antimicrobial activity from stems and leaves of Paris polyphylla var. yunnanensis. Steroids (2012) 0.82
Building high-throughput molecular junctions using indented graphene point contacts. Angew Chem Int Ed Engl (2012) 0.82
Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin Chim Acta (2005) 0.82
Structural and functional changes mapped in the brains of amyotrophic lateral sclerosis patients with/without dysphagia: a pilot study. Amyotroph Lateral Scler (2009) 0.82
Diffusion tensor MRI for the assessment of cerebral ischemia/reperfusion injury in the penumbra of non-human primate stroke model. Neurol Res (2010) 0.82
Heparin cofactor II levels do not predict the development of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol (2005) 0.82
Differential dissolved protein expression throughout the life cycle of Giardia lamblia. Exp Parasitol (2012) 0.81
[An epidemiological study on factors affecting serum thyroglobulin levels]. Zhonghua Nei Ke Za Zhi (2003) 0.81
Influence of silencing soluble epoxide hydrolase with RNA interference on cardiomyocytes apoptosis induced by doxorubicin. J Huazhong Univ Sci Technolog Med Sci (2011) 0.81
Analysis of risk factors for retinopathy of prematurity. Int J Ophthalmol (2011) 0.81
Acupuncture for Bell's palsy. J Altern Complement Med (2009) 0.81
Contra-diffusion synthesis of ZIF-8 films on a polymer substrate. Chem Commun (Camb) (2011) 0.81
Cerebrolysin for vascular dementia. Cochrane Database Syst Rev (2013) 0.81
N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate. Glycobiology (2006) 0.81
Direct intrahepatic portocaval shunt through transhepatic puncture via retrohepatic inferior vena cava: applied anatomical study. Surg Radiol Anat (2008) 0.81